Dexmedetomidine for Postoperative Sedation Following Stereotactic Lead Placement

Hope Xu; Anthony H. Bui; Maite La Vega-Talbott; Sheemon P. Zackai

doi:10.1055/s-0039-1687882

Journal of Pediatric Neurology, Table of Contents

Journal of Pediatric Neurology 2020; 18(03): 157-160
DOI: 10.1055/s-0039-1687882

Case Report

Georg Thieme Verlag KG Stuttgart · New York

Dexmedetomidine for Postoperative Sedation Following Stereotactic Lead Placement

Hope Xu ^*

¹Department of Pediatrics, Icahn School of Medicine at Mount Sinai, Kravis Children's Hospital at Mount Sinai, New York, New York, United States

,

Anthony H. Bui^*

¹Department of Pediatrics, Icahn School of Medicine at Mount Sinai, Kravis Children's Hospital at Mount Sinai, New York, New York, United States

,

Maite La Vega-Talbott

²Department of Neurology, Pediatric Neurology, Kravis Children's Hospital at Mount Sinai, New York, New York, United States

,

Sheemon P. Zackai

³Department of Pediatrics, Pediatric Critical Care Medicine, Kravis Children's Hospital at Mount Sinai, New York, New York, United States

› Author Affiliations

Abstract

Dexmedetomidine has become an increasingly popular alternative to benzodiazepines and opioids as a safe agent for sedation and pain control, especially in pediatric populations. In this study, we present a case of postoperative use of dexmedetomidine in a pediatric patient, with a known history of behavioral difficulties, who underwent stereotactic lead placement for medically refractory epilepsy.

Keywords

dexmedetomidine - Precedex - stereoelectroencephalography - stereotactic lead placement - epilepsy - sedation

Full Text

References

References
1 Lüders HO, Najm I, Nair D, Widdess-Walsh P, Bingman W. The epileptogenic zone: general principles. Epileptic Disord 2006; 8 (Suppl. 02) S1-S9
2 Chabardes S, Abel TJ, Cardinale F, Kahane P. Commentary: understanding stereoelectroencephalography: what's next?. Neurosurgery 2018; 82 (01) E15-E16
3 Avanzini G. Discussion of stereoelectroencephalography. Acta Neurol Scand Suppl 1994; 152: 70-73
4 Bancaud J, Dell MB. Technics and method of stereotaxic functional exploration of the brain structures in man (cortex, subcortex, central gray nuclei) [article in French]. Rev Neurol (Paris) 1959; 101: 213-227
5 Cossu M, Chabardès S, Hoffmann D, Lo Russo G. [Presurgical evaluation of intractable epilepsy using stereo-electro-encephalography methodology: principles, technique and morbidity]. Neurochirurgie 2008; 54 (03) 367-373
6 Gonzalez-Martinez J, Mullin J, Vadera S. , et al. Stereotactic placement of depth electrodes in medically intractable epilepsy. J Neurosurg 2014; 120 (03) 639-644
7 Sacino MF, Huang SS, Schreiber J, Gaillard WD, Oluigbo CO. Is the use of stereotactic electroencephalography safe and effective in children? A meta-analysis of the use of stereotactic electroencephalography in comparison to subdural grids for invasive epilepsy monitoring in pediatric subjects. Neurosurgery 2019; 84 (06) 1190-1200
8 Short JA, Calder A. Anaesthesia for children with special needs, including autistic spectrum disorder. Contin Educ Anaesth Crit Care Pain 2013; 13 (04) 107-112
9 Vlassakova BG, Emmanouil DE. Perioperative considerations in children with autism spectrum disorder. Curr Opin Anaesthesiol 2016; 29 (03) 359-366
10 Gupta S, Singh D, Sood D, Kathuria S. Role of dexmedetomidine in early extubation of the intensive care unit patients. J Anaesthesiol Clin Pharmacol 2015; 31 (01) 92-98
11 Hammer GB, Drover DR, Cao H. , et al. The effects of dexmedetomidine on cardiac electrophysiology in children. Anesth Analg 2008; 106 (01) 79-83
12 Jessen Lundorf L, Korvenius Nedergaard H, Møller AM. Perioperative dexmedetomidine for acute pain after abdominal surgery in adults. Cochrane Database Syst Rev 2016; 2: CD010358
13 Lee HS, Yoon HY, Jin HJ, Hwang SH. Can dexmedetomidine influence recovery profiles from general anesthesia in nasal surgery?. Otolaryngol Head Neck Surg 2018; 158 (01) 43-53
14 Massad IM, Mohsen WA, Basha AS, Al-Zaben KR, Al-Mustafa MM, Alghanem SM. A balanced anesthesia with dexmedetomidine decreases postoperative nausea and vomiting after laparoscopic surgery. Saudi Med J 2009; 30 (12) 1537-1541
15 Duan X, Coburn M, Rossaint R, Sanders RD, Waesberghe JV, Kowark A. Efficacy of perioperative dexmedetomidine on postoperative delirium: systematic review and meta-analysis with trial sequential analysis of randomised controlled trials. Br J Anaesth 2018; 121 (02) 384-397
16 Piao G, Wu J. Systematic assessment of dexmedetomidine as an anesthetic agent: a meta-analysis of randomized controlled trials. Arch Med Sci 2014; 10 (01) 19-24
17 Ahmed SS, Unland T, Slaven JE, Nitu ME, Rigby MR. Successful use of intravenous dexmedetomidine for magnetic resonance imaging sedation in autistic children. South Med J 2014; 107 (09) 559-564
18 Franklin AD, Sobey JH, Stickles ET. Anesthetic considerations for pediatric electroconvulsive therapy. Paediatr Anaesth 2017; 27 (05) 471-479
19 Koroglu A, Demirbilek S, Teksan H, Sagir O, But AK, Ersoy MO. Sedative, haemodynamic and respiratory effects of dexmedetomidine in children undergoing magnetic resonance imaging examination: preliminary results. Br J Anaesth 2005; 94 (06) 821-824
20 De Benedictis A, Trezza A, Carai A. , et al. Robot-assisted procedures in pediatric neurosurgery. Neurosurg Focus 2017; 42 (05) E7
21 Xu KL, Liu XQ, Yao YL. , et al. Effect of dexmedetomidine on rats with convulsive status epilepticus and association with activation of cholinergic anti-inflammatory pathway. Biochem Biophys Res Commun 2018; 495 (01) 421-426
22 Zhai MZ, Wu HH, Yin JB. , et al. Dexmedetomidine dose-dependently attenuates ropivacaine-induced seizures and negative emotions via inhibiting phosphorylation of amygdala extracellular signal-regulated kinase in mice. Mol Neurobiol 2016; 53 (04) 2636-2646
23 Tanaka K, Oda Y, Funao T, Takahashi R, Hamaoka N, Asada A. Dexmedetomidine decreases the convulsive potency of bupivacaine and levobupivacaine in rats: involvement of alpha2-adrenoceptor for controlling convulsions. Anesth Analg 2005; 100 (03) 687-696
24 Talke P, Stapelfeldt C, Garcia P. Dexmedetomidine does not reduce epileptiform discharges in adults with epilepsy. J Neurosurg Anesthesiol 2007; 19 (03) 195-199
25 Chaitanya G, Arivazhagan A, Sinha S. , et al. Dexmedetomidine anesthesia enhances spike generation during intra-operative electrocorticography: a promising adjunct for epilepsy surgery. Epilepsy Res 2015; 109: 65-71
26 Souter MJ, Rozet I, Ojemann JG. , et al. Dexmedetomidine sedation during awake craniotomy for seizure resection: effects on electrocorticography. J Neurosurg Anesthesiol 2007; 19 (01) 38-44
27 Ard J, Doyle W, Bekker A. Awake craniotomy with dexmedetomidine in pediatric patients. J Neurosurg Anesthesiol 2003; 15 (03) 263-266
28 Fernandes ML, do Carmo Santos M, Gomez RS. Sedation with dexmedetomidine for conducting electroencephalogram in a patient with Angelman syndrome: a case report. Braz J Anesthesiol 2016; 66 (02) 212-214
29 Takahashi Y, Ueno K, Ninomiya Y, Eguchi T, Nomura Y, Kawano Y. Potential risk factors for dexmedetomidine withdrawal seizures in infants after surgery for congenital heart disease. Brain Dev 2016; 38 (07) 648-653
30 Ghai B, Jain K, Saxena AK, Bhatia N, Sodhi KS. Comparison of oral midazolam with intranasal dexmedetomidine premedication for children undergoing CT imaging: a randomized, double-blind, and controlled study. Paediatr Anaesth 2017; 27 (01) 37-44
31 Mahmoud M, Gunter J, Donnelly LF, Wang Y, Nick TG, Sadhasivam S. A comparison of dexmedetomidine with propofol for magnetic resonance imaging sleep studies in children. Anesth Analg 2009; 109 (03) 745-753
32 Qiao H, Xie Z, Jia J. Pediatric premedication: a double-blind randomized trial of dexmedetomidine or ketamine alone versus a combination of dexmedetomidine and ketamine. BMC Anesthesiol 2017; 17 (01) 158
33 Mason KP, Zgleszewski S, Forman RE, Stark C, DiNardo JA. An exaggerated hypertensive response to glycopyrrolate therapy for bradycardia associated with high-dose dexmedetomidine. Anesth Analg 2009; 108 (03) 906-908
34 Buck ML, Willson DF. Use of dexmedetomidine in the pediatric intensive care unit. Pharmacotherapy 2008; 28 (01) 51-57
35 Guinter JR, Kristeller JL. Prolonged infusions of dexmedetomidine in critically ill patients. Am J Health Syst Pharm 2010; 67 (15) 1246-1253
36 Miller JL, Allen C, Johnson PN. Neurologic withdrawal symptoms following abrupt discontinuation of a prolonged dexmedetomidine infusion in a child. J Pediatr Pharmacol Ther 2010; 15 (01) 38-42